The Food and Drug Administration has decided at least 60 million doses of Johnson & Johnson’s coronavirus vaccine made at the problem-plagued Emergent BioSolutions plant must be discarded, according to an individual familiar with the situation.
The agency, after an extensive safety review, also is releasing 10 million doses for use, according to the individual and to a statement released by the agency on Friday. The statement said “several other batches are not suitable for use, but additional batches are still under review.”